Digma Medical
4 known investors
Find your way into Digma Medical
Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus. The device is designed for use in standard GI endoscopy suites and serves gastroenterology clinicians treating pre-cancerous and other GI pathologies.
Investors · 4
How we know: Accelmed Partners's portfolio page · Not right? Tell us
How we know: Incentive, Peregrine Ventures Incubator's portfolio page · Not right? Tell us
How we know: Peregrine Ventures's portfolio page · Not right? Tell us
How we know: Tal Ventures's portfolio page · the VCSheet dataset · Not right? Tell us
Founder mafia
3 people who came through Digma Medical went on to found or lead other companies.
Frequently asked questions
- What does Digma Medical do?
- Digma Medical develops the Endoscopic Gastrointestinal Ablation Device (EGAD), a minimally invasive therapy using a console and single-use catheter for contactless, imaging-guided ablation of esophageal mucosal tissue, initially targeting Barrett's Esophagus. The device is designed for use in standard GI endoscopy suites and serves gastroenterology clinicians treating pre-cancerous and other GI pathologies.
- Who are Digma Medical's investors?
- Digma Medical's investors include Accelmed Partners, Incentive, Peregrine Ventures Incubator, Peregrine Ventures, Tal Ventures.





